Reversible posterior leukoencephalopathy syndrome

Onkologie

Volumn 30, Issue 3, 2007, Pages 90-91

  Norden, A D ^a   Batchelor, T T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COLON TUMOR; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EDITORIAL; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; HYPERTENSION; LETHARGY; LEUKOENCEPHALOPATHY; LUMBAR PUNCTURE; MENINGOENCEPHALITIS; MENTAL DEFICIENCY; NEUROIMAGING; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE; OCCIPITAL LOBE; POSTERIOR CEREBRAL ARTERY; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; STUPOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN DISEASES; COLONIC NEOPLASMS; FEMALE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; REMISSION, SPONTANEOUS;

EID: 33847743066     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098642     Document Type: Editorial

References (18)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Kinoshita T, Moritani T, Shrier DA, Hiwatashi A, Wang HZ, Numaguchi Y, Westesson PL: Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. Clin Imaging 2003;27:307-15.
3. Mukherjee P, McKinstry RC: Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756-65.
4. Schiff D, Lopes MB: Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2005;2:303-5.
5. Allen JA, Adlakha A, Bergethon PR: Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006;63:1475-8.
6. Ozcan C, Wong SJ, Hari P: Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980-2; discussion 980-2.
7. Glusker P, Recht L, Lane B: Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980-2; discussion 980-2.
8. Govindarajan R, Adusumilli J, Baxter DL, El-Khoueiry A, Harik SI: Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol 2006;24:e48.
9. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, Gonzalez RG, Koroshetz WJ: Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369-76.
10. Ahn KJ, You WJ, Jeong SL, Lee JW, Kim BS, Lee JH, Yang DW, Son YM, Hahn ST: Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004;46:978-83.
11. Stott VL, Hurrell MA, Anderson TJ: Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 2005;35:83-90.
12. Henderson RD, Rajah T, Nicol AJ, Read SJ: Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003;60:326-8.
13. Haefner MD, Siciliano RD, Widmer LA, Vogel Wigger BM, Frick S: Reversible Posterior Leukoencephalopathy Syndrome after Treatment of Diffuse Large B-Cell Lymphoma. Onkologie 2007;30:138-140.
14. Caplan LR: 'Top of the basilar' syndrome. Neurology 1980;30:72-9.
15. Roos KL: Lumbar puncture. Semin Neurol 2003;23:105-14.
16. Edwards MJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM: Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001;12:1327-9.
17. Kastrup O, Diener HC: Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol 1997;244:274-5.
18. Thaipisuttikul I, Phanthumchinda K: Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005;252:230-1.